1. Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia. (1st October 2019) Authors: Huang, Shujuan; Pan, Jiajia; Jin, Jing; Li, Chengying; Li, Xia; Huang, Jiansong; Huang, Xin; Yan, Xiao; Li, Fengling; Yu, Mengxia; Hu, Chao; Jin, Jingrui; Xu, Yu; Ling, Qing; Ye, Wenle; Wang, Yungui; Jin, Jie Journal: Cancer letters Issue: Volume 461(2019) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration. (January 2021) Authors: Han, Xiaoyan; Jin, Chunxiang; Zheng, Gaofeng; Li, Yi; Wang, Yungui; Zhang, Enfan; Zhu, Honghu; Cai, Zhen Journal: Therapeutic advances in hematology Issue: Volume 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia. Issue 2 (28th March 2016) Authors: Huang, Hao; Jiang, Xi; Wang, Jinhua; Li, Yuanyuan; Song, Chun-Xiao; Chen, Ping; Li, Shenglai; Gurbuxani, Sandeep; Arnovitz, Stephen; Wang, Yungui; Weng, Hengyou; Neilly, Mary Beth; He, Chuan; Li, Zejuan; Chen, Jianjun Journal: Cancer letters Issue: Volume 372:Issue 2(2016) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Improved long‐term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide‐based front‐line therapy. Issue 3 (3rd June 2018) Authors: Lou, Yinjun; Lu, Ying; Zhu, Zhijuan; Ma, Yafang; Suo, Shanshan; Wang, Yungui; Chen, Dong; Tong, Hongyan; Qian, Wenbin; Meng, Haitao; Mai, Wenyuan; Yu, Wenjun; Xu, Weilai; Wang, Lei; Mao, Liping; Pei, Renzhi; Jin, Jie Journal: Hematological oncology Issue: Volume 36:Issue 3(2018) Page Start: 584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Investigating clinical characteristics and prognostic factors in patients with chronic osteomyelitis of humerus. Issue 1 (5th December 2019) Authors: Wu, Hongri; Yu, Shengpeng; Fu, Jingshu; Sun, Dong; Wang, Shulin; Xie, Zhao; Wang, Yungui Journal: Burns and trauma Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PML‐RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy‐free postremission approach: A multiple institution experience. Issue 4 (29th July 2020) Authors: Lou, Yinjun; Lu, Ying; Ye, Xingnong; Wang, Yungui; Ma, Yafang; Fan, Cuihua; Jiang, Huifang; Jin, Jie Journal: Hematological oncology Issue: Volume 38:Issue 4(2020) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy. Issue 9 (September 2015) Authors: Lou, Yinjun; Ma, Yafang; Suo, Shanshan; Ni, Wanmao; Wang, Yungui; Pan, Hanzhang; Tong, Hongyan; Qian, Wenbin; Meng, Haitao; Mai, Wenyuan; Huang, Jian; Yu, Wenjuan; Wei, Juyin; Mao, Liping; Jin, Jie Journal: Leukemia research Issue: Volume 39:Issue 9(2015:Sep.) Page Start: 938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. T315L: a novel mutation within BCR-ABL kinase domain confers resistance against ponatinib. Issue 7 (3rd July 2017) Authors: Wang, Dongmei; Pan, Hanzhang; Wang, Yungui Journal: Leukemia & lymphoma Issue: Volume 58:Issue 7(2017) Page Start: 1733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Venetoclax plus '2 + 5' modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis. (2nd March 2023) Authors: Wang, Huafeng; Yao, Yiyi; Mao, Liping; Lou, Yinjun; Ren, Yanling; Ye, Xingnong; Yang, Min; Ma, Liya; Zhang, Yi; Zhou, Yile; Wu, Jiaying; Huang, Xin; Wang, Yungui; Xu, Huan; Tong, Hongyan; Zhu, Hong‐Hu; Jin, Jie Journal: British journal of haematology Issue: Volume 201:Number 3(2023) Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial. Issue 6 (June 2022) Authors: Wang, Huafeng; Mao, Liping; Yang, Min; Qian, Pengxu; Lu, Huan; Tong, Hongyan; Xie, Wanzhuo; Zhou, De; Huang, Xin; Wang, Yungui; Xu, Gaixiang; Lu, Ying; Wei, Juying; Mai, Wenyuan; Ye, Xiujin; Meng, Haitao; Shen, Yaojia; Huang, Jian; Yu, Wenjuan; Sun, Jie Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗